Official UK procurement notice
Community Pharmacy COVID-19 Vaccination Programme Phase 5 2021/22
Authority: NHS England (Central government)·Consortium: 2 public authorities
The National Health Service Commissioning Board (which uses the operational name "NHS England") is seeking to enter into local enhanced services arrangements with community pharmacies in geographical areas where NHS England identifies there is a need for additional COVID-19 vaccination capacity. NHS is a global leader in achieving high levels of vaccination coverage, and this has been reflected in a hugely successful COVID-19 vaccination programme.
What is being bought
Published requirement descriptionThe National Health Service Commissioning Board (which uses the operational name "NHS England") is seeking to enter into local enhanced services arrangements with community pharmacies in geographical areas where NHS England identifies there is a need for additional COVID-19 vaccination capacity. Successful community pharmacies will provide COVID-19 vaccination services under a local enhanced services agreement at designated sites operated by the pharmacies.www.england.nhs.uk/coronavirus/covid-19… ↗
CPV: Community health services · Health services
The lotProcurement structure
single lot · value publishedLot #1NHS is a global leader in achieving high levels of vaccination coverage, and this has…RenewalPublished value£10
NHS is a global leader in achieving high levels of vaccination coverage, and this has been reflected in a hugely successful COVID-19 vaccination programme. Community pharmacy has played a critical role in the success of phase 1 (the vaccination of patient JCVI cohorts 1-9) and phase 2 (the vaccination of patient JCVI cohorts 10-12) of the COVID-19 vaccination programme. Through their strong relationships in local places and neighbourhoods, community pharmacies have helped to tackle vaccine inequalities and improve vaccination take-up.<br/>The fifth phase of the COVID-19 vaccination programme will offer booster (with additional vaccine) for those at the highest risk, to maintain protection against the risk of severe illness, and continue to offer initial vaccinations to those Patients who did not take up or were previously not eligible to receive vaccination in phases 1 and 2.<br/>The service will be provided as a Local Enhanced Service (LES) pursuant to the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013. The Community Pharmacy Phase 5 Site Designation Process document sets out the detail of how Pharmacy Contractor can submit expressions of interest for providing the LES and how Pharmacy Contractors who are able to provide the LES will be identified at a regional basis on the basis of site. The LES Agreement document sets out the requirements of service provision. A LES Agreement will be entered into between NHS England and a Pharmacy Contractor selected by NHS England via the Site Designation Process which is set out in the Community Pharmacy Phase 5 Site Designation Process document but only where there is a local population need for additional COVID-19 vaccination services and where NHS England considers the relevant Pharmacy Contractor is best placed to meet that need having applies the criteria, process and steps outlined in the Community Pharmacy Phase 5 Site Designation Process document.<br/>For the avoidance of doubt, this is a voluntary Contract Notice in the interests of achieving maximum transparency and sectoral awareness. NHS England is empowered to facilitate LES Agreements on a site by site basis pursuant to the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013.<br/>The items of service payment of £10.06 per vaccination administered to a Patient
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
- Price
- Suitability
Pursuant to direction 14 of the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013, NHS England is only authorised to arrange for the provision of an enhanced service with Pharmacy Contractors which are defined as persons included in a list prepared under regulation 10(2)(a) of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Closed
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Yes
- First published
- 15 Jul 2021, 17:25 BST
- Last source update
- 11 Jul 2022, 08:36 BST
- Award evaluation window
- 29 Jun 2022 – …
- FTS notice number
2022/S 000-018842- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02c88cFind a Tender
Publisher note: This is a voluntary Contract Notice. LES Agreements are authorised pursuant to direction 14 of the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013. In any event, the services in scope are healthcare services which fall under “social and other specific services” in Section 7.. All Pharmacy Contractors that submit Expressions of Interest will set out in Stage 1 of Designation Process (as set out in the Community Pharmacy Phase 3 Designation Process document) will then go through a prioritisation process with the application of locality specific criteria to identify Priority Sites which will then go through an assurance process. Any such Assured Sites will then be subject to an assessment of readiness preparation with NHS England. Where NHS England is so satisfied, the site will be approved and a LES Agreement offered. If NHS England considers that there is a need for additional COVID-19 vaccination services in a geographical area covered by the Pharmacy Contractor who submitted an Expression of Interest, NHS England may either publish an invitation to submit new Expressions of Interest with specific detail as to the specific requirements or revisit the Expressions of Interest originally submitted and progress other Pharmacy Contractors through the Designation Process again. There will be no maximum number of Pharmacy Contractors that may be offered a LES Agreement. Each LES Agreement is likely to be below the financial threshold for services.
How it was run
Official noticeTender documents are also served through a separate tool: https://health-family.force.com/s/Welcome ↗
- Submission deadline
- 19 Jul 2022, 17:00 BST
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Bid validity
- 90 days from the deadline
- Bids opened
- 29 Jun 2022, 12:00 BST
Timeline
29 Jun 2022 → 19 Jul 2022 · 3 dates- Bids opened29 Jun 2022, 12:00 BST
- Notice published11 Jul 2022, 08:36 BST
- Submission deadline19 Jul 2022, 17:00 BST
Notice history
7 events · 6 releases on Find a Tender · since 25 Nov 2021- Deadline moved to 2 Dec 2021, 17:00 GMT25 Nov 2021, 16:11 GMT+2 days · was 30 Nov 2021, 17:00 GMT
- Deadline moved to 30 Nov 2021, 17:00 GMT25 Nov 2021, 16:11 GMT+125 days · was 28 Jul 2021, 17:00 BST
- Published value published: £1320 May 2022, 14:17 BST
- Deadline moved to 27 May 2022, 12:00 BST20 May 2022, 14:17 BST+176 days · was 2 Dec 2021, 17:00 GMT
- Buyer details updated20 May 2022, 14:17 BST
- Published value updated to £1029 Jun 2022, 16:48 BSTwas £13
- Deadline moved to 19 Jul 2022, 17:00 BST29 Jun 2022, 16:48 BST+53 days · was 27 May 2022, 12:00 BST
Published amendments (2 · 1 deadline change)
| When | What | Before | After | Shift |
|---|---|---|---|---|
| — | DeadlineDeadline for EOI date · IV.2.2.1 | 30 Nov 2021 | 2 Dec 2021 | +2 d |
| — | Contract periodEnd Date · II.2.7.4 | — | 31 Mar 2023 |
2 amendments published without a description.
Routine re-releases (6)
- 2021-11: 2 releases · 25 Nov 2021
- 2021-07: 1 release · 15 Jul 2021
Contracting authority & participating public bodies
2 public bodies on the noticeConsortium members and other public bodies
- The NHS Commissioning Board (operating under the name of NHS England)Contracting authorityMinistry or any other national or federal authority, including their regional or local subdivisionsHealth
Dispute resolution & review bodies
- The High CourtReview body
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.